Skip to main content
. 2014 Jan;35(1):3–9. doi: 10.3174/ajnr.A3437

Fig 1.

Fig 1.

Specific to IA, the preclinical phase between formation and symptom development/rupture can be quite variable, and the clinical phase between symptom development and SAH/death can be quite short or nonexistent. Lead time is dependent on screening frequency. DPCP indicates detectable preclinical phase. Adapted from Morrison65 by permission of Oxford University Press, USA.